Medicare Enrolled
Dr. Ahmad El-Far, M.D.
Hematology & Oncology · Winter Haven, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. El-Far from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. El-Far?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. El-Far
Dr. Ahmad El-Far is a hematology & oncology specialist in Winter Haven, FL, with 15 years of NPI registration. Based on federal Medicare data, Dr. El-Far performed 242,699 Medicare services across 5,288 unique beneficiaries.
Between the years covered by Open Payments, Dr. El-Far received a total of $8,369 from 53 pharmaceutical and/or device companies across 300 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. El-Far is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 2% volume in FL
$8,369 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 131283 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗242,699
Medicare services
Top 2% in FL for hematology & oncology
5,288
Unique beneficiaries
$3
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~16,180 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
156,000 | $1 | $2 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
20,120 | $6 | $21 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
18,870 | $0 | $2 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
10,480 | $6 | $19 |
| Denosumab injection (Prolia/Xgeva) | 7,140 | $19 | $41 |
| Injection, heparin sodium, (heparin lock flush), per 10 units | 4,625 | $0 | $1 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
4,551 | $0 | $0 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,555 | $0 | $0 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,772 | $8 | $16 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,767 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,510 | $1 | $12 |
| Anti-nausea injection (ondansetron/Zofran) | 1,504 | $0 | $0 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
991 | $10 | $21 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
841 | $11 | $42 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
763 | $63 | $150 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
706 | $10 | $40 |
| Iron level test | 636 | $6 | $13 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
620 | $1 | $1 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
613 | $13 | $27 |
| Transferrin level test A blood test that measures the amount of transferrin, a protein that binds to and transports iron in the body. |
607 | $12 | $26 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
550 | $93 | $218 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
542 | $6 | $12 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
422 | $4 | $9 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
414 | $16 | $64 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
401 | $15 | $30 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
384 | $14 | $29 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
371 | $22 | $91 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
365 | $98 | $411 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
317 | $48 | $208 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
298 | $1 | $2 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
219 | $21 | $89 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
204 | $19 | $38 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
171 | $54 | $230 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
142 | $132 | $294 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
120 | $63 | $148 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
108 | $1 | $3 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
89 | $1 | $4 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
76 | $23 | $100 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
74 | $123 | $333 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
72 | $49 | $200 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
66 | $16 | $34 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
57 | $101 | $283 |
| PSA test (prostate cancer screening) | 52 | $18 | $37 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
45 | $19 | $72 |
| CT scan of chest with and without contrast A computed tomography scan of the chest performed using both intravenous contrast dye and without it to provide detailed images of internal structures. |
40 | $107 | $680 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
39 | $94 | $213 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
38 | $24 | $93 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
37 | $5 | $10 |
| Blood urea nitrogen test A blood test that measures the amount of urea nitrogen to assess kidney function. |
37 | $4 | $8 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
37 | $40 | $68 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
31 | $263 | $1,077 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
27 | $4 | $8 |
| New patient office visit, complex (60-74 min) | 26 | $149 | $421 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
26 | $135 | $414 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
20 | $8 | $17 |
| Urine culture, bacterial identification A laboratory test that grows and identifies bacteria from a urine sample to detect infections. |
20 | $8 | $34 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
17 | $96 | $576 |
| Complete x-ray of body bones An x-ray imaging procedure that captures images of the entire skeletal system. |
17 | $72 | $280 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
17 | $7 | $13 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
15 | $22 | $96 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
14 | $25 | $52 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
11 | $238 | $959 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
73.0% high complexity
22.3% medium
4.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,369
Total received (2018-2024)
Avg $1,395/year across 6 years
Top 39% in FL for hematology & oncology
53
Companies
300
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,414 (88.6%)
Other
Charitable contributions, space rental, and other categories
$632 (7.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$323 (3.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,838
2023
$2,537
2022
$1,892
2021
$47
2019
$35
2018
$19
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
US Oncology Corporate, Inc.
$1,383
Novartis Pharmaceuticals Corporation
$869
PFIZER INC.
$685
Daiichi Sankyo Inc.
$452
Merck Sharp & Dohme LLC
$430
Incyte Corporation
$363
Lilly USA, LLC
$314
NOVARTIS PHARMACEUTICALS CORPORATION
$299
Gilead Sciences, Inc.
$277
Celgene Corporation
$270
AstraZeneca Pharmaceuticals LP
$248
Janssen Biotech, Inc.
$232
Kite Pharma, Inc.
$218
Bayer Healthcare Pharmaceuticals Inc.
$171
Genentech USA, Inc.
$164
ABBVIE INC.
$145
E.R. Squibb & Sons, L.L.C.
$135
GENZYME CORPORATION
$131
Astellas Pharma US Inc
$131
Aveo Pharmaceuticals, Inc.
$123
Seagen Inc.
$104
GlaxoSmithKline, LLC.
$93
Blueprint Medicines Corporation
$82
Mylan Institutional Inc.
$81
SOBI, INC
$77
Pharmacosmos Therapeutics Inc.
$64
AVEO Pharmaceuticals, Inc.
$61
TAIHO ONCOLOGY, INC.
$58
Rigel Pharmaceuticals, Inc.
$54
Takeda Pharmaceuticals U.S.A., Inc.
$49
Global Blood Therapeutics, Inc.
$47
Ipsen Biopharmaceuticals, Inc
$41
PUMA BIOTECHNOLOGY, INC.
$38
Biocompatibles, Inc.
$35
Regeneron Healthcare Solutions, Inc.
$34
Amgen Inc.
$33
CTI BioPharma Corp.
$32
Bayer HealthCare Pharmaceuticals Inc.
$31
Verity Pharmaceuticals Inc.
$30
Fennec Pharmaceuticals, Inc.
$25
Dendreon Pharmaceuticals LLC
$25
Eisai Inc.
$24
Alexion Pharmaceuticals, Inc.
$23
Spectrum Pharmaceuticals Inc.
$23
Deciphera Pharmaceuticals Inc.
$23
Sobi, Inc
$21
Boston Scientific Corporation
$20
Agios Pharmaceuticals, Inc.
$20
Kyowa Kirin, Inc.
$18
Merck Sharp & Dohme Corporation
$17
Foundation Medicine, Inc.
$17
MACROGENICS, INC.
$14
Puma Biotechnology, Inc.
$13
Top 3 companies account for 35.1% of total payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AYVAKIT · BOSULIF · CABLIVI · CALQUENCE · CYRAMZA · Columvi · DOPTELET · Doptelet · ELIQUIS · ENHERTU · ERLEADA · Enhertu · FOTIVDA · FOUNDATIONONE · Fabhalta · IBRANCE · INJECTAFER · INLYTA · JAKAFI · JAYPIRCA · JEVTANA · KEYTRUDA · KISQALI · LIBTAYO · LONSURF · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · MARGENZA · MEKINIST · MONOFERRIC · NERLYNX · NINLARO · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · OXBRYTA · Ogivri · Onivyde · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · PYRUKYND · Pedmark · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RETEVMO · ROLVEDON · SARCLISA · SCEMBLIX · SHINGRIX · Somatuline Depot · Stivarga · TASIGNA · TECVAYLI · THERASPHERE-BIO · Tavalisse · Tecentriq · Trelstar · VENCLEXTA · VERZENIO · VONJO · Vanflyta · Vonjo · XTANDI · Xtandi · Yescarta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (89%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $3 per 100 Medicare services performed
Geographic Context
Hematology & oncology specialists within 10 mi
14
Per 100K population
1.8
County median income
$63,644
Nearest hospital
WINTER HAVEN HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. El-Far is a mixed practice specialist, with above-average Medicare volume (top 2% in FL), with low-engagement industry engagement, with 15 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. El-Far experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. El-Far performed 156,000 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. El-Far receive payments from pharmaceutical companies?
Yes. Dr. El-Far received a total of $8,369 from 53 companies across 300 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. El-Far's costs compare to other hematology & oncology specialists in Winter Haven?
Dr. El-Far's average Medicare payment per service is $3. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. El-Far) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Winter Haven
Browse hematology & oncology specialists in Winter Haven ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
US Oncology Corporate, Inc. Payments to Doctors
See all physicians who received payments from US Oncology Corporate, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology